Of particular note, the info docs received from sales reps did not adequately address the harms from drugs. See Mintzes et al. https://t.co/K84POY9pTD "physicians were rarely informed about serious adverse events"
Ir kādi piemēri par Latviju? https://t.co/5UzvVO00F0
Bet kad vecāki saka, ka potēm ir blaknes, ne visas vajag utt. - tad viņi ir galīgie idioti https://t.co/mecZXXNuVK
RT @cmrherder: .@innovativemeds Are you suggesting Cdn drug reps don't selectively present info? That's simply false https://t.co/g2Ad6SEYl…
RT @cmrherder: .@innovativemeds Are you suggesting Cdn drug reps don't selectively present info? That's simply false https://t.co/g2Ad6SEYl…
.@innovativemeds Are you suggesting Cdn drug reps don't selectively present info? That's simply false https://t.co/g2Ad6SEYls @DavidJuurlink
Pharmaceutical Sales Representatives and Patient Safety: A Study in Canada, France and the United States. http://t.co/nyOMPdzN1D
Pharmaceutical Sales Representatives and Patient Safety: A Study in Canada, France and the United States. http://t.co/nyOMPdzN1D
Representantes farmacéuticos y seguridad del paciente. Un estudio en Canadá, Francia y EEUU. http://t.co/nyOMPdzN1D
Representantes farmacéuticos y seguridad del paciente. Un estudio en Canadá, Francia y EEUU. http://t.co/nyOMPdzN1D
Representantes farmacéuticos y seguridad del paciente. Un estudio en Canadá, Francia y EEUU. http://t.co/nyOMPdzN1D
Pharmaceutical Sales Representatives and Patient Safety: A Study in Canada, France and the United States. http://t.co/nyOMPdzN1D
Pharmaceutical Sales Representatives and Patient Safety http://t.co/oOKpgcaj3G
Pharmaceutical Sales Representatives and Patient Safety http://t.co/oOKpgcaj3G
Pharmaceutical Sales Reps & Patient Safety (Misinformation): A Comparative Prospective Study http://t.co/Dx4wonLp0K
Pharmaceutical Sales and #ptSafety:comparative study of Information Quality in Canada_France and the US http://t.co/M0WNWPgBU9 #springerlink
New research out from #PPRC experts Barbara Mintzes, Joel Lexchin et al. on pharma sales reps & patient safety: http://t.co/ljwkm8cTBB
Interesting. "@CADTH_ACMTS: MT @PharmaPolicy New research out #PPRC experts on #pharma sales reps & #patientsafety http://t.co/u5RI3eU0qy
Interesting. "@CADTH_ACMTS: MT @PharmaPolicy New research out #PPRC experts on #pharma sales reps & #patientsafety http://t.co/u5RI3eU0qy
Interesting. "@CADTH_ACMTS: MT @PharmaPolicy New research out #PPRC experts on #pharma sales reps & #patientsafety http://t.co/u5RI3eU0qy
New research out from #PPRC experts Barbara Mintzes, Joel Lexchin et al. on pharma sales reps & patient safety: http://t.co/ljwkm8cTBB
MT @PharmaPolicy New research out from #PPRC experts on #pharma sales reps & #patientsafety http://t.co/YEkgOYawOU
Coauthored by @CHSPR's Jason Sutherland: MT @PharmaPolicy: New research on pharma sales reps & patient safety: http://t.co/xSqDEPzv7f
New research out from #PPRC experts Barbara Mintzes, Joel Lexchin et al. on pharma sales reps & patient safety: http://t.co/ljwkm8cTBB
New research out from #PPRC experts Barbara Mintzes, Joel Lexchin et al. on pharma sales reps & patient safety: http://t.co/ljwkm8cTBB
RT @jsross119: @JournalGIM During Pharma sales calls in US, France & Canada, docs rarely informed about drug safety http://t.co/ccUvwl7QVt
RT @jsross119: @JournalGIM During Pharma sales calls in US, France & Canada, docs rarely informed about drug safety http://t.co/Poki0EV7eV
@JournalGIM During Pharma sales calls in US, France & Canada, docs rarely informed about drug safety http://t.co/zHaAUiWnaG
Sales Representatives/Patient Safety: Comparative Prosp. Study of Inform. Quality in Canada, France and US http://t.co/WzZCpwvdpY
Dr. Barbara Mintzes shows in #JGIM doctors not often informed of harmful #drugsideeffects during sales rep visits. http://t.co/OROYyIR6R4
Peu d’informations sur les effets secondaires des médicaments par les VM, étude comparative in J Gen Intern Med http://t.co/iGvtHLz9mw
RT @rosermarquet: Pharmaceutical Sales Representatives and Patient Safety:http://t.co/b9btvznysm #springerlink
Pharmaceutical Sales Representatives and Patient Safety:http://t.co/b9btvznysm #springerlink
http://t.co/fvJlSsWJw5 Pharmaceutical Sales Representatives and Patient Safety A Study of Information Quality in Canada, France and US
Pharmaceutical Sales Rep and Patient Safety A Comparative Study of Information Quality in Canada, France and the USA http://t.co/sfbG72bO6f
Pharmaceutical Sales Representatives and Patient Safety http://t.co/JLwims1qy8 #springerlink
RT @DTB_BMJ: Pharma sales reps fail to mention drug-related harm 60% of the time and rarely mention serious adverse effects. http://t.co/VgL27wU1ax
Concerns highlighted over the lack of safety information provided to clinicians by pharmaceutical sales... http://t.co/9v6TgFXxCx
Pharma sales reps fail to mention drug-related harm 60% of the time and rarely mention serious adverse effects. http://t.co/VgL27wU1ax
Study: Pharm Sales Reps & drug info, & 5 alternative sources: http://t.co/yGF1JZuFTH & http://t.co/QHCBzF8ejf. Do we agree, health libs?
RT @patdeegan: Study finds pharma sales reps offer little information on harmful effects but docs ready to prescribe http://t.co/ZfyYpijLLO
Study finds pharma sales reps offer little information on harmful effects but docs ready to prescribe http://t.co/ZfyYpijLLO
JGIM: ¿Informan los delegados de la industria sobre efectos adversos?. Parece que no según estudio en 3 países. http://t.co/0BUdWuMMmE
JGIM: ¿Informan los delegados de la industria sobre efectos adversos?. Parece que no según estudio en 3 países. http://t.co/0BUdWuMMmE
Pharma reps warned physicians about serious adverse effects of drugs they were selling only 5% of the time http://t.co/mIT3nqXiUf
Omisiones peligrosas: Visitadores médicos e información sobre seguridad de los medicamentos http://t.co/jvUY1VWxia … vía @RafaBravo
Drug representatives rarely inform physicians about adverse drug effects and complications, http://t.co/R9kJgKmy7O
Pharmaceutical Sales Reps and Patient Safety http://t.co/Ww9OOwsoXv
RT @RichmondDoc: PhRMA claims its reps help educate docs about meds...but try don't educate abou safety concerns http://t.co/C9ybneaEhj
RT @ChronicPainGPS: Putting #patientsafety at risk! #cphc MT @RichmondDoc Drug reps only tell Drs abt serious side effects 5% of time: http://t.co/XK3uUQVHHo
RT @ChronicPainGPS: Putting #patientsafety at risk! #HCLDR MT @RichmondDoc Drug reps only tell Drs abt serious side effects 5% of time: http://t.co/XK3uUQVHHo
Pharmaceutical Sales Representatives and Patient Safety: A Comparative Prospective Study… http://t.co/YU8xAKJUGF #pharma #ptsafety
Pharmaceutical Sales Representatives and Patient Safety: A Comparative Prospective Study… http://t.co/YU8xAKJUGF #pharma #ptsafety
Pharmaceutical Sales Representatives and Patient Safety: A Comparative Prospective Study… http://t.co/YU8xAKJUGF #pharma #ptsafety
@JournalGIM paper shows Phrma reps rarely inform physicians about serious adverse events when detailing their drugs http://t.co/Y7eF4NEyu5
Pharmaceutical Sales Representatives and Patient Safety http://t.co/c5A60kzsZh
Pharmaceutical Sales Representatives and Patient Safety: A Comparative Prospective Study of Informat - http://t.co/UOO2XUKCSo
Etude comparative sur la qualité de l'information sur le médicament en France, au Canada et aux Etats-Unis. http://t.co/0CQo7fmhm4
Doctors report that drug reps only tell them about side effects 5% of the time. http://t.co/67LylAWXr7
Omisiones peligrosas: Visitadores médicos e información sobre seguridad de los medicamentos http://t.co/jvUY1VWxia … vía @RafaBravo
@DCTian New study showing sales reps do not tell docs about bad side effects of brand-name drugs.... http://t.co/30N8b0D12l
Omisiones peligrosas: Visitadores médicos e información sobre seguridad de los medicamentos http://t.co/0aXMd0xUlv vía @RafaBravo
Un ejemplo de lo que no se cuenta en la visita médica http://t.co/IzepwnuPgb @sierralibi
Omisiones peligrosas: Visitadores médicos e información sobre seguridad de los medicamentos http://t.co/0aXMd0xUlv vía @RafaBravo
Pharmaceutical Sales Representatives and Patient Safety: A Comparative Prospective Study of Information Quality http://t.co/4cUcoNsrtS
Physicians rarely detailed on ADRs by pharmaceutical reps. 1.7% received “minimally adequate safety information” http://t.co/qhruFu7gnV
Doctors rarely informed by sales reps about side-effects; even when drugs have a "black box" warning. #bigpharma http://t.co/XwF9jxqhJx
Doctors rarely informed by sales reps about side-effects; even when drugs have a "black box" warning. #bigpharma http://t.co/XwF9jxqhJx
RT @IvanWolffers: Artsenbezoekers vertellen artsen bijna niets over bijwerkingen. http://t.co/niGcN4KFxk Wat moet arts met zulke informatie?
Artsenbezoekers vertellen artsen bijna niets over bijwerkingen. http://t.co/yiJjRZs2dg Wat moet arts met zulke informatie?
Artsenbezoekers vertellen artsen bijna niets over bijwerkingen. http://t.co/yiJjRZs2dg Wat moet arts met zulke informatie?
カナダの研究【Vancouver Sun】Doctors often not informed of drugs' harmful effects during sales visits http://t.co/WX3ZUZ3jIH http://t.co/WfUMmXwLYE
Minimal Drug safety info is seldom given by pharma sales reps; 54% judge Rx info as good/excellent, <6% mention SAE http://t.co/Jao9M3dJma
La seguridad del paciente se obvia en la información sanitaria (representantes), aun siendo una obligación legal http://t.co/YYwKNmz3Vv
La seguridad del paciente se obvia en la información sanitaria (representantes), aun siendo una obligación legal http://t.co/YYwKNmz3Vv
Pharma Sales Reps & Patient Safety: Comparative Prospective Study of Info Quality in Canada, France and the US http://t.co/zao4kHGfCr
Weer eens een onderzoek waardoor je begrijpt dat arts vaak niet tegen artsenbezoeker op kan. http://t.co/yiJjRZs2dg Overschatting.
Doctors not informed of harmful effects of medicines during sales visits: http://t.co/xvGOKbKsrl. http://t.co/0t0f9p2X7Y
Dr. Barbara Mintzes shows in #JGIM doctors not often informed of harmful #drugsideeffects during sales rep visits. http://t.co/OROYyIR6R4
They're not telling us about harms: http://t.co/RDOo8CxHuC Just one of the reasons I don't see drug reps.
RT @JPRiviere: Etude USA Canada France : les médecins "rarement informés des effets indésirables graves" par les visiteurs médicaux http://t.co/dAxAGpkRc0
RT @JPRiviere: Etude USA Canada France : les médecins "rarement informés des effets indésirables graves" par les visiteurs médicaux http://t.co/dAxAGpkRc0
Etude USA Canada France : les médecins "rarement informés des effets indésirables graves" par les visiteurs médicaux http://t.co/dAxAGpkRc0